Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Hypolipidemic Agents

Concept
uri icon
  • Overview
scroll to property group menus

Overview

subject area of

  • A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (ppar alpha) versus liver x receptor  Academic Article
  • Aortocoronary saphenous vein graft disease - pathogenesis, predisposition, and prevention  Academic Article
  • Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: An observational study  Academic Article
  • In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization - a propensity analysis  Academic Article
  • Opposing roles of peroxisome proliferator-activated receptor alpha and growth hormone in the regulation of CYP4A11 expression in a transgenic mouse model  Academic Article
  • Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention  Academic Article
  • Relation between previous lipid-lowering therapy and infaret size (creatine kinase-mb level) in patients presenting with acute myocardial infarction  Academic Article
  • Strategies to achieve coronary arterial plaque stabilization  Academic Article
  • The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand  Academic Article
  • Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the united states, europe, and canada  Academic Article

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support